Alberta Cancer Board
Last Modified: January 15, 2006
Conference Dates: Thursday, March 2, 2006 to Monday, March 6, 2006
Conference Location: The Fairmont Banff Springs Hotel, Banff, Alberta
Sponsoring Group: Alberta Cancer Board
Conference Web Page URL: http://www.buksa.com
Conference Objectives: What should the next adjuvant melanoma trial be (the experimental arm, what vaccines, what molecules…)? Can we be rational about selecting investigational molecular therapies / methods, based on what we know about the biology of the disease? Is DTIC still the standard in metastatic disease? Have we made any progress in metastatic disease?
Who Should Attend: Medical Oncologists, Surgeons (General, Oncological, Plastics), Dermatologists, Pathologists, Molecular Biologists, Immunologists
Conference Agenda: TBA
Registration Information: For More Information Canadian Melanoma Conference Secretariat BUKSA Conference Management and Program Development Tel: 780.436.0983 Ext. 229 Fax: 780.437.5984 Toll Free (within North America): 866.436.0983 Ext. 229 Email: firstname.lastname@example.org.
Conference Fees: Regular: $250.00 (CDN) - Student: $150.00 (CDN) - One Day: $100.00
Continuing Education: Yes
Nov 11, 2010 - Long-term use of statins for cholesterol control is unlikely to significantly increase or decrease overall cancer risk but may reduce the risk for some individual cancers, according to a study presented at the American Association for Cancer Research's Frontiers in Cancer Prevention Research Conference, held from Nov. 7 to 10 in Philadelphia.
Nov 11, 2010
Oct 26, 2011
Nov 24, 2014